Melola Discovery

← Melola Discovery

Jurnal SINTA 1

HORMONAL STATUS (ESTROGEN RECEPTORS - PROGESTERONE) AND HER-2 Neu IN VARIOUS CYCLIN D1 EXPRESSIONS IN BREAST CANCER

Folia Medica Indonesiana · Vol. 46 No. 4 (2010)

ISSN
2355-8393, 2599-056X
Terbit
2010-10-01
Penerbit
Airlangga University
Bahasa
en

Abstrak

Breast cancer is the most common malignancy and leading death cause of malignancy in women in the world. Expression of estrogen receptors (ER) and progesterone receptors (PR) has long been used to determine endocrine therapy patients. Family of human epidermal growth factor receptor, namely (HER-2/neu) has been used as markers to predict prognosis and therapy response. But many ductal breast carcinoma patients showed expression of ER, PR, and HER-2 neu negative (triple negative tumors). There should be further research for patients with triple negative tumors, to find prognostic markers and therapies. The purposed of this study was to analyze the relationship between hormonal status and HER-2 expression with cyclin D1expression in breast ductal carcinoma. This study was an observational analytic study, conducted at the Department of Pathology Faculty of Medicine Airlangga University/Dr. Soetomo. Paraffin blocks of 35 patients with invasive ductal breast carcinoma, which has not been treated with anti-cancer drug, in a variety hormonal status and HER-2 neu expression, followed by immunohistochemical examination. The results obtained, 31.4% patients in the age group 50 to 59 years. Cyclin D1 positive expression in 54.3% samples, and positive in 87.5% samples with ER positive and negative in 55.6% samples with negative ER. In positive PR sample, cyclin D1 positive in 72.7% samples, and cyclin D1 negative in 54.2% samples with negative PR.. Also showed that cyclin D1 positive in 85.7% samples with HER-2 positive and negative in 66.7% samples with HER-2 negative. In conclusion, there is a positive correlation between expression of ER and HER-2 neu by cyclin D1 expression.

Kata kunci

Jaringan kolaborasi para penulis

14 penulis · 33 tautan kepenulisan bersama · 7 lintas organisasi

Arahkan kursor atau ketuk sebuah nama untuk menyorot rekan penulisnya. Klik dua kali untuk membuka halaman penulis.

  • Universitas Airlangga
  • Rumah Sakit Dokter Soetomo
  • Tadulako University
  • Afiliasi tidak diketahui
  • Organisasi berbeda
  • Organisasi sama
  • Afiliasi tidak diketahui
  • Garis lebih tebal = lebih banyak artikel bersama · lingkaran lebih besar = lebih banyak artikel
Tampilkan sebagai tabel
Rekan penulisOrganisasiArtikel bersama
Junaidi KhotibUniversitas Airlangga3
Gondo MastutikUniversitas Airlangga2
Alphania RahniayuUniversitas Airlangga2
Anny Setijo RahajuUniversitas Airlangga2
Mahardian RahmadiUniversitas Airlangga2
Budi HarjantoRumah Sakit Dokter Soetomo1
Dewi Perwito SariUniversitas Airlangga1
Sjahjenny MustokoweniUniversitas Airlangga1
Rahmi AliaAfiliasi tidak diketahui1
Selvi MegawatiUniversitas Airlangga1
Yuyun WirasasmitaTadulako University1

Afiliasi berasal dari OpenAlex; metadata OAI-PMH jurnal tidak memuatnya. Penulis tanpa ID OpenAlex dicocokkan berdasarkan nama, sehingga dua orang bisa tergabung atau satu orang bisa terpisah.

Sumber metadata: OpenAlex API (jurnal SINTA, ADR 0048) https://openalex.org/S4210179714, pertama di-harvest 19 Nov 2026, terakhir terlihat 19 Nov 2026.
Metadata asli (oai_dc)
<oai_dc:dc xmlns:dc="http://purl.org/dc/elements/1.1/" xmlns:oai_dc="http://www.openarchives.org/OAI/2.0/oai_dc/"><dc:title xml:lang="en">HORMONAL STATUS (ESTROGEN RECEPTORS - PROGESTERONE) AND HER-2 Neu IN VARIOUS CYCLIN D1 EXPRESSIONS IN BREAST CANCER</dc:title><dc:creator>Imam Susilo</dc:creator><dc:creator>Imelda Theodora</dc:creator><dc:creator>Nila Kurniasari</dc:creator><dc:subject>breast cancer</dc:subject><dc:subject>cyclin D1</dc:subject><dc:subject>estrogen receptor</dc:subject><dc:subject>progesterone receptor</dc:subject><dc:subject>HER2/neu</dc:subject><dc:subject>triple-negative breast cancer</dc:subject><dc:subject>invasive ductal carcinoma</dc:subject><dc:subject>hormonal status</dc:subject><dc:subject>prognostic factors</dc:subject><dc:subject>endocrine therapy</dc:subject><dc:description xml:lang="en">Breast cancer is the most common malignancy and leading death cause of malignancy in women in the world. Expression of estrogen receptors (ER) and progesterone receptors (PR) has long been used to determine endocrine therapy patients. Family of human epidermal growth factor receptor, namely (HER-2/neu) has been used as markers to predict prognosis and therapy response. But many ductal breast carcinoma patients showed expression of ER, PR, and HER-2 neu negative (triple negative tumors). There should be further research for patients with triple negative tumors, to find prognostic markers and therapies. The purposed of this study was to analyze the relationship between hormonal status and HER-2 expression with cyclin D1expression in breast ductal carcinoma. This study was an observational analytic study, conducted at the Department of Pathology Faculty of Medicine Airlangga University/Dr. Soetomo. Paraffin blocks of 35 patients with invasive ductal breast carcinoma, which has not been treated with anti-cancer drug, in a variety hormonal status and HER-2 neu expression, followed by immunohistochemical examination. The results obtained, 31.4% patients in the age group 50 to 59 years. Cyclin D1 positive expression in 54.3% samples, and positive in 87.5% samples with ER positive and negative in 55.6% samples with negative ER. In positive PR sample, cyclin D1 positive in 72.7% samples, and cyclin D1 negative in 54.2% samples with negative PR.. Also showed that cyclin D1 positive in 85.7% samples with HER-2 positive and negative in 66.7% samples with HER-2 negative. In conclusion, there is a positive correlation between expression of ER and HER-2 neu by cyclin D1 expression.</dc:description><dc:publisher>Airlangga University</dc:publisher><dc:date>2010-10-01</dc:date><dc:type>info:eu-repo/semantics/article</dc:type><dc:identifier>http://www.journal.unair.ac.id/filerPDF/14%2011002%20ImamE%20-%20Format%20FMI.pdf</dc:identifier><dc:source>Folia Medica Indonesiana; Vol 46 No 4 (2010)</dc:source><dc:source>2355-8393</dc:source><dc:source>2599-056X</dc:source><dc:language>en</dc:language></oai_dc:dc>